National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 11) (PB 100 of 2019) (Cth)

PB 100 of 2019

National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 11)

National Health Act 1953

___________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated      27 November 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

_________________________________________________________________________

1. Name of Instrument

(1)This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2019 (No. 11).

(2)This Instrument may also be cited as PB 100 of 2019.

1. Commencement

This Instrument commences on 1 December 2019.

1. Amendment of National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

1. Schedule 1, after entry for Fluoxetine in the form Tablet, dispersible, 20 mg (as hydrochloride)

insert:

Fluticasone propionate with salmeterol	Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)	Inhalation by Mouth	Seretide MDI 125/25	1	34.56	38.28
Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation)	Inhalation by Mouth	Seretide MDI 250/25	1	46.78	50.50

1. Schedule 1, entry for Triamcinolone with Neomycin, Gramicidin and Nystatin

omit:

Ear drops containing triamcinolone acetonide 1 mg with neomycin 2.5 mg (as sulfate), gramicidin 250 micrograms and nystatin 100,000 units per g, 7.5 mL Application to the ear Kenacomb Otic 1 3.78 5.36

substitute:

Ear drops containing triamcinolone acetonide 0.9 mg with neomycin 2.25 mg (as sulfate), gramicidin 225 micrograms and nystatin 90,000 units per g, 7.5 mL Application to the ear Kenacomb Otic 1 3.78 5.36

1. Schedule 1, entry for Trimethoprim with Sulfamethoxazole

omit:

Tablet 160 mg‑800 mg	Oral	Bactrim DS	10	1.76	3.78
Septrin Forte	10	1.76	5.64

substitute:

Tablet 160 mg‑800 mg Oral Septrin Forte 10 1.76 5.64